-
Blood 04/2011; 117(16):4400-1. · 9.90 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Like other lymphocytes, natural killer (NK) cells need to develop tolerance toward self. In the last decade, major progress has been made in understanding the molecular mechanisms behind this phenomenon. Yet the cellular mechanisms regulating the education of NK cells remain poorly understood. This study aimed to unravel the cellular mechanisms regulating NK-cell tolerance in the context of alloreactivity.
Using the classical hybrid resistance model and an in vivo cytotoxicity assay, we examined host NK-cell alloreactivity against donor hematopoietic cells in the presence of long-term stable chimerism.
We demonstrate persisting host NK-cell alloreactivity against donor hematopoietic cells, despite the presence of long-term stable chimerism. This NK-cell alloreactivity decreases with increasing levels of parental chimerism.
Our results indicate that long-term mixed hematopoietic chimerism does not necessarily imply the induction of full NK-cell nonresponsiveness. NK-cell nonresponsiveness is, therefore, not an absolute phenomenon, but represents a dynamic process, balancing NK-cell alloreactivity against the size of the transplanted allogeneic stem cell pool.
Experimental hematology 05/2009; 37(6):739-43. · 3.11 Impact Factor
-
Blood 07/2007; 109(12):5524-5. · 9.90 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Mesenchymal stem cells (MSCs) are multipotent progenitor cells that have emerged as a promising tool for clinical application. Further clinical interest has been raised by the observation that MSCs are immunoprivileged and, more important, display immunosuppressive capacities. These properties may be of therapeutic value in allogeneic transplantation to prevent graft rejection and to prevent and treat graft-versus-host disease. In the present study, we examined the in vivo immunomodulatory properties of MSCs in murine models of allogeneic bone marrow (BM) transplantation. Sublethally irradiated recipients received allogeneic BM with or without host or donor MSCs. The addition of host MSCs significantly enhanced the long-term engraftment associated with tolerance to host and donor antigens. However, the infusion of donor MSCs was associated with significantly increased rejection of allogeneic donor BM cells. Moreover, we showed that the injection of merely allogeneic donor MSCs in naive mice was sufficient to induce a memory T-cell response. Although the observed engraftment-promoting effects of host MSCs in vivo support the therapeutic potential of MSCs, our results also indicate that allogeneic MSCs are not intrinsically immunoprivileged and that under appropriate conditions, allogeneic MSCs induce a memory T-cell response resulting in rejection of an allogeneic stem cell graft.
Blood 10/2006; 108(6):2114-20. · 9.90 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: T-cell tolerance is mandatory for major histocompatibility complex (MHC)-mismatched stem-cell transplantation without cytoreduction. Here, we used a cytotoxicity assay based on the infusion of differentially carboxyfluorescein succinimidyl ester (CFSE)-labeled syngeneic and donor splenocytes to determine the survival of donor cells in vivo. In vivo cytotoxicity data showed that treatment with anti-CD40 ligand monoclonal antibody in combination with a low dose of MHC-mismatched bone marrow cells was sufficient to induce T-cell tolerance. However, CFSE-labeled donor cells were still eliminated. A similar elimination pattern was observed in T-cell and natural killer T-cell (NKT-cell)-deficient mice, suggesting the involvement of natural killer (NK) cells. Indeed, in vivo NK-cell depletion resulted in a prolonged survival of CFSE-labeled donor cells, confirming the role of NK cells in this process. Transplantation of a megadose of MHC-mismatched bone marrow cells was required for a complete survival of CFSE-labeled donor cells. This NK-cell tolerance was donor specific and was associated with mixed chimerism. Additional NK-cell depletion significantly enhanced engraftment and allowed long-term chimerism after transplantation of a relatively low dose of donor bone marrow cells. These data demonstrate the importance of NK cells in the rejection of MHC-mismatched hematopoietic cells and may explain the high numbers of bone marrow cells required for transplantation over MHC barriers.
Blood 10/2005; 106(6):2215-20. · 9.90 Impact Factor
